KYRNF vs ABBV: Which Stock is Better?
Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Abbvie Inc in 2026
KYRNF
KYORIN Pharmaceutical Co., Ltd.
$10.31
ABBV
Abbvie Inc
$208.38
Key Metrics Comparison
| Metric | KYRNF | ABBV | Winner |
|---|---|---|---|
| Market Cap | $592.33M | $369.65B | ABBV |
| P/E Ratio | 10.11 | 88.56 | KYRNF |
| EPS (TTM) | $1.02 | $2.36 | ABBV |
| Revenue Growth | -0.0% | 0.1% | ABBV |
| Gross Margin | 45.3% | 71.6% | ABBV |
Analyze KYRNF
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYRNF or ABBV a better investment?
Comparing KYRNF and ABBV: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Abbvie Inc has $369.65B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYRNF and ABBV?
KYRNF (KYORIN Pharmaceutical Co., Ltd.) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYRNF or ABBV?
Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 88.6x).
Which is growing faster: KYRNF or ABBV?
ABBV has higher revenue growth at 0.1% vs -0.0% for KYRNF.
Which company is more profitable: KYRNF or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 45.3% for KYRNF.
Which is the larger company: KYRNF or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $369.65B compared to $592.33M for KYRNF.
Should I buy KYRNF or ABBV in 2026?
Both KYRNF and ABBV have investment merit. KYRNF trades at $10.31 while ABBV trades at $208.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYRNF and ABBV stock?
Key differences: Market Cap ($592.33M vs $369.65B), P/E Ratio (10.1x vs 88.6x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (45.3% vs 71.6%).